STIPE Therapeutics ApS — Credit Rating and Financial Key Figures

STIPE Therapeutics ApS (CVR number: 39691175) is a company from KØBENHAVN. The company recorded a gross profit of -3456.6 kEUR in 2023. The operating profit was -4957.6 kEUR, while net earnings were -4456.1 kEUR. The profitability of the company measured by Return on Assets (ROA) was -82.7 %, which can be considered poor and Return on Equity (ROE) was -172.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -43.7 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. STIPE Therapeutics ApS's liquidity measured by quick ratio was 5.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.